Showing results (911-920 of 1,351) with videos related to

Sort By:
Pageof 136
Clinical Pharmacology in Drug Development|April 24, 2018
Absolute Bioavailability of Osimertinib in Healthy AdultsKarthick Vishwanathan, Karen So, Karen Thomas, et al.
Clinical Pharmacology in Drug Development|June 20, 2018
Pharmacokinetics, Pharmacodynamics, and Safety of Subcutaneous Bapineuzumab: A Single-Ascending-Dose Study in Patients With Mild to Moderate Alzheimer DiseaseMing Lu, H Robert Brashear
Clinical Pharmacology in Drug Development|June 2, 2018
Pharmacokinetic Characteristics of Tofacitinib in Adult Patients With Moderate to Severe Chronic Plaque PsoriasisGuangli Ma, Rujia Xie, Bruce Strober, et al.
Clinical Pharmacology in Drug Development|July 23, 2020
Effect of Hepatic Impairment on Cobimetinib Pharmacokinetics: The Complex Interplay Between Physiological Changes and Drug CharacteristicsSravanthi Cheeti, Yuzhong Deng, Ilsung Chang, et al.
Clinical Pharmacology in Drug Development|April 22, 2021
Pharmacokinetics of Ginsenoside Compound K From a Compound K Fermentation Product, CK-30, and From Red Ginseng Extract in Healthy Korean SubjectsMu Seong Ban, Yun Kim, Sunyoung Lee, et al.
Clinical Pharmacology in Drug Development|May 21, 2023
Pharmacokinetics, Bioequivalence, and Safety Evaluation of 2 Formulations of 10-mg Rivaroxaban Tablets: A 4-Period Crossover TrialCanhua Zhang, Zihan Shen, Jianhao Li, et al.
Clinical Pharmacology in Drug Development|May 22, 2023
Pharmacokinetics, Safety, and Tolerability of Brivaracetam in Healthy Elderly ParticipantsArmel Stockis, Jean-Marie Nicolas, Maria Laura Sargentini-Maier, et al.
Clinical Pharmacology in Drug Development|May 19, 2023
Pharmacokinetics of Enarodustat in Non-Japanese and Japanese Healthy Subjects and in Patients With End-Stage Renal Disease on HemodialysisSudhakar M Pai, Siva Rama Prasad Kambhampati, Shinya Naruhashi, et al.
Clinical Pharmacology in Drug Development|August 22, 2025
Pharmacokinetics and Pharmacodynamics of Faldaprevir Following Multiple Oral Rising Doses in Healthy Volunteers and Subjects with Gilbert's SyndromeMabrouk Elgadi, Chan-Loi Yong, Jan Wruck, et al.
Clinical Pharmacology in Drug Development|March 20, 2023
Safety, Tolerability, and Pharmacokinetics of IMU-935, a Novel Inverse Agonist of Retinoic Acid Receptor-Related Orphan Nuclear Receptor γt: Results From a Double-Blind, Placebo-Controlled, First-in-Human Phase 1 StudyThomas M Polasek, Indika Leelasena, Irina Betscheider, et al.
Pageof 136